[Membranous microparticles and respiratory disease]

Rev Mal Respir. 2017 Dec;34(10):1058-1071. doi: 10.1016/j.rmr.2017.10.005. Epub 2017 Nov 11.
[Article in French]

Abstract

Microparticles (MP) are plasmic membrane fragments released from cells after physiological stimulation or stress conditions like inflammation or infection. Their production is correlated to the rate of cell apoptosis. All types of cells can produce MP but they are produced mainly by platelets, endothelial cells, and leukocytes. They carry many bio-active molecules on their surface, specific to the parental cell, giving them the ability to be biomarkers and bio-effectors. MP are present in circulating blood, tissues and many biological fluids. Circulating MP levels can change during the course of many diseases. They have been the subject of many studies in the fields of cardiovascular disease and oncology. In the lungs, they are present in circulating blood and in the airways. They seem to have a role in pulmonary homeostasis in physiological situations and also in the expression of several disease processes. In this review of the literature, we were interested in the quantitative and qualitative variations in MP and their impact in airway diseases like chronic obstructive pulmonary disease (COPD) and asthma, pulmonary fibrosis and pulmonary hypertension.

Keywords: Bio-effecters;Biomarkers;Cells;Microparticles; Bio-effecteurs; Biomarqueurs; Cellules; Microparticules.

Publication types

  • Review

MeSH terms

  • Biomarkers / analysis*
  • Biomarkers / metabolism
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / metabolism
  • Cell-Derived Microparticles / physiology*
  • Humans
  • Respiration Disorders / diagnosis*
  • Respiration Disorders / etiology*
  • Respiratory Tract Diseases / diagnosis
  • Respiratory Tract Diseases / etiology
  • Respiratory Tract Diseases / metabolism

Substances

  • Biomarkers